Tapewire

Nasdaq · USD

JSPR

Jasper Therapeutics, Inc.

Export transactions ↓
Tapewire entity
7588
SEC CIK
0001788028
Parsed reports
158

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 11, 2020 Filed Dec 15, 2020 23:26 UTC
GLAZER PAUL J10% owner
SaleClass A common stock, par value $0.0001 per share 5,000 $10.05 $50,250.00
Disclosure

SEC source: 0001076809-20-000328 · amhc20201215.xml · nonDerivative · entry 1

GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner

GLAZER PAUL J · CIK 0001133985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote 1.

Disclosed balance after: 1,108,218

F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
December 07, 2020 Filed Dec 10, 2020 00:02 UTC
GLAZER PAUL J10% owner
SaleClass A common stock, par value $0.0001 per share 1 $10.05 $10.05
Disclosure

SEC source: 0001076809-20-000303 · amhcform4.xml · nonDerivative · entry 2

GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner

GLAZER PAUL J · CIK 0001133985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote 1.

Disclosed balance after: 1,113,218

F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
September 21, 2020 Filed Sep 23, 2020 20:28 UTC
GLAZER PAUL J10% owner
SaleClass A Common Stock 1,000 $10.00 $10,000.00
Disclosure

SEC source: 0001076809-20-000165 · primary_doc.xml · nonDerivative · entry 1

GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner

GLAZER PAUL J · CIK 0001133985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote 1.

Disclosed balance after: 1,113,230

F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
September 18, 2020 Filed Sep 18, 2020 21:39 UTC
GLAZER PAUL J10% owner
SaleClass A Common Stock 1,000 $10.00 $10,000.00
Disclosure

SEC source: 0001076809-20-000160 · primary_doc.xml · nonDerivative · entry 2

GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner

GLAZER PAUL J · CIK 0001133985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote 1.

Disclosed balance after: 1,114,230

F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
September 16, 2020 Filed Sep 18, 2020 21:39 UTC
GLAZER PAUL J10% owner
SaleClass A Common Stock 20 $9.99 $199.80
Disclosure

SEC source: 0001076809-20-000160 · primary_doc.xml · nonDerivative · entry 1

GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner

GLAZER PAUL J · CIK 0001133985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote 1.

Disclosed balance after: 1,115,230

F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
September 15, 2020 Filed Sep 15, 2020 20:05 UTC
GLAZER PAUL J10% owner
SaleClass A Common Stock 800 $9.99 $7,992.00
Disclosure

SEC source: 0001076809-20-000157 · primary_doc.xml · nonDerivative · entry 2

GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner

GLAZER PAUL J · CIK 0001133985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote 1.

Disclosed balance after: 1,115,250

F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
September 11, 2020 Filed Sep 15, 2020 20:05 UTC
GLAZER PAUL J10% owner
SaleClass A Common Stock 682 $9.99 $6,813.18
Disclosure

SEC source: 0001076809-20-000157 · primary_doc.xml · nonDerivative · entry 1

GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner

GLAZER PAUL J · CIK 0001133985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote 1.

Disclosed balance after: 1,116,050

F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
September 08, 2020 Filed Sep 10, 2020 20:02 UTC
GLAZER PAUL J10% owner
SaleClass A Common Stock 1 $9.99 $9.99
Disclosure

SEC source: 0001076809-20-000147 · primary_doc.xml · nonDerivative · entry 1

GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner

GLAZER PAUL J · CIK 0001133985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote 1.

Disclosed balance after: 1,116,732

F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
September 04, 2020 Filed Dec 10, 2020 00:02 UTC
GLAZER PAUL J10% owner
SaleClass A common stock, par value $0.0001 per share 11 $10.73 $118.03
Disclosure

SEC source: 0001076809-20-000303 · amhcform4.xml · nonDerivative · entry 1

GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner

GLAZER PAUL J · CIK 0001133985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote 1.

Disclosed balance after: 1,113,219

F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
August 17, 2020 Filed Aug 18, 2020 00:19 UTC
GLAZER PAUL J10% owner
SaleClass A Common Stock 1,699 $9.99 $16,973.01
Disclosure

SEC source: 0001076809-20-000132 · primary_doc.xml · nonDerivative · entry 2

GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner

GLAZER PAUL J · CIK 0001133985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote 1.

Disclosed balance after: 1,116,733

F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
August 13, 2020 Filed Aug 18, 2020 00:19 UTC
GLAZER PAUL J10% owner
SaleClass A Common Stock 1,699 $9.99 $16,973.01
Disclosure

SEC source: 0001076809-20-000132 · primary_doc.xml · nonDerivative · entry 1

GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner

GLAZER PAUL J · CIK 0001133985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote 1.

Disclosed balance after: 1,118,432

F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 18:01 UTC
VENKATARAMAN BALAJIDirector · Chief Executive Officer · 10% owner
OtherClass B Common Stock · Derivative 375,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-20-000421 · ownership.xml · derivative · entry 1

VENKATARAMAN BALAJI · CIK 0001114916 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,500,000

Underlying: Class A Common Stock · 375,000 shares

Expires not disclosed

F1 · derivative.exercise_price: As described in the issuer's registration statement on Form S-1 (File No. 333-234324) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustment described therein and have no expiration date.

F2 · kind: As contemplated in connection with the initial public offering of the issuer, 375,000 shares of Class B common stock were returned by Amplitude Healthcare Holdings LLC (the "Sponsor") to the issuer for no consideration and cancelled because the underwriters' over-allotment option was not exercised at all.

F1 · derivative.exercise_date: As described in the issuer's registration statement on Form S-1 (File No. 333-234324) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustment described therein and have no expiration date.

F1 · derivative.expiration_date: As described in the issuer's registration statement on Form S-1 (File No. 333-234324) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustment described therein and have no expiration date.

F3 · ownership.nature: These shares represent the Class B common stock of the Sponsor acquired pursuant to a subscription agreement by and between the Sponsor and the issuer. Mr. Venkataraman, the Chief Executive Officer and a director of the issuer, is the manager of Avego Healthcare Capital, LLC, which is a managing member of the Sponsor and shares the voting and dispositive power of the securities held by the Sponsor. Accordingly, each of Mr. Venkataraman and Avego Healthcare Capital, LLC may be deemed to share beneficial ownership of such shares. Each of Mr. Venkataraman and Avego Healthcare Capital, LLC disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 23:01 UTC
HOFFEN HOWARD IDirector · 10% owner
OtherClass B Common Stock · Derivative 375,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-20-000420 · ownership.xml · derivative · entry 1

HOFFEN HOWARD I · CIK 0001208810 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,500,000

Underlying: Class A Common Stock · 375,000 shares

Expires not disclosed

F1 · derivative.exercise_price: As described in the issuer's registration statement on Form S-1 (File No. 333-234324) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustment described therein and have no expiration date.

F2 · kind: As contemplated in connection with the initial public offering of the issuer, 375,000 shares of Class B common stock were returned by Amplitude Healthcare Holdings LLC (the "Sponsor") to the issuer for no consideration and cancelled because the underwriters' over-allotment option was not exercised at all.

F1 · derivative.exercise_date: As described in the issuer's registration statement on Form S-1 (File No. 333-234324) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustment described therein and have no expiration date.

F1 · derivative.expiration_date: As described in the issuer's registration statement on Form S-1 (File No. 333-234324) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustment described therein and have no expiration date.

F3 · ownership.nature: These shares represent the Class B common stock of the issuer held by the Sponsor acquired pursuant to a subscription agreement by and between the Sponsor and the issuer. Mr. Hoffen, the Chairman of the issuer, is a partner of Metalmark Capital II LLC ("Metalmark"), which is the sole member Metalmark Capital Holdings LLC. The partners of Metalmark indirectly control Metalmark Capital Holdings LLC, which is the general partner of Metalmark Capital Partners III GP, L.P., the sole member of Metalmark Amplitude Healthcare Holdings LLC. Metalmark Amplitude Healthcare Holdings LLC is a managing member of the Sponsor and shares the voting and dispositive power of the securities held by the Sponsor.

F4 · ownership.nature: Accordingly, each of Mr. Hoffen, Metalmark Amplitude Healthcare Holdings LLC, Metalmark Capital Partners III GP, L.P., Metalmark Capital Holdings LLC and Metalmark Capital II LLC may be deemed to share beneficial ownership of such shares. Each of Mr. Hoffen, Metalmark Amplitude Healthcare Holdings LLC, Metalmark Capital Partners III GP, L.P., Metalmark Capital Holdings LLC and Metalmark Capital II LLC, disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 18:00 UTC
Clifford Kenneth FChief Financial Officer · 10% owner
OtherClass B Common Stock · Derivative 375,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-20-000419 · ownership.xml · derivative · entry 1

Clifford Kenneth F · CIK 0001333753 · Chief Financial Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,500,000

Underlying: Class A Common Stock · 375,000 shares

Expires not disclosed

F1 · derivative.exercise_price: As described in the issuer's registration statement on Form S-1 (File No. 333-234324) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustment described therein and have no expiration date.

F2 · kind: As contemplated in connection with the initial public offering of the issuer, 375,000 shares of Class B common stock were returned by Amplitude Healthcare Holdings LLC (the "Sponsor") to the issuer for no consideration and cancelled because the underwriters' over-allotment option was not exercised at all.

F1 · derivative.exercise_date: As described in the issuer's registration statement on Form S-1 (File No. 333-234324) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustment described therein and have no expiration date.

F1 · derivative.expiration_date: As described in the issuer's registration statement on Form S-1 (File No. 333-234324) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustment described therein and have no expiration date.

F3 · ownership.nature: These shares represent the Class B common stock of the issuer held by the Sponsor acquired pursuant to a subscription agreement by and between the Sponsor and the issuer. Mr. Clifford, the Chief Financial Officer of the issuer, is a partner of Metalmark Capital II LLC ("Metalmark"), which is the sole member Metalmark Capital Holdings LLC. The partners of Metalmark indirectly control Metalmark Capital Holdings LLC, which is the general partner of Metalmark Capital Partners III GP, L.P., the sole member of Metalmark Amplitude Healthcare Holdings LLC. Metalmark Amplitude Healthcare Holdings LLC is a managing member of the Sponsor and shares the voting and dispositive power of the securities held by the Sponsor.

F4 · ownership.nature: Accordingly, each of Mr. Clifford, Metalmark Amplitude Healthcare Holdings LLC, Metalmark Capital Partners III GP, L.P., Metalmark Capital Holdings LLC and Metalmark Capital II LLC may be deemed to share beneficial ownership of such shares. Each of Mr. Clifford, Metalmark Amplitude Healthcare Holdings LLC, Metalmark Capital Partners III GP, L.P., Metalmark Capital Holdings LLC and Metalmark Capital II LLC, disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 18:00 UTC OtherClass B Common Stock · Derivative 375,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-20-000418 · ownership.xml · derivative · entry 1

Amplitude Healthcare Holdings LLC · CIK 0001788269 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500,000

Underlying: Class A Common Stock · 375,000 shares

Expires not disclosed

F1 · derivative.exercise_price: As described in the issuer's registration statement on Form S-1 (File No. 333-234324) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustment described therein and have no expiration date.

F2 · kind: As contemplated in connection with the initial public offering of the issuer, 375,000 shares of Class B common stock were returned by Amplitude Healthcare Holdings LLC (the "Sponsor") to the issuer for no consideration and cancelled because the underwriters' over-allotment option was not exercised at all.

F1 · derivative.exercise_date: As described in the issuer's registration statement on Form S-1 (File No. 333-234324) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustment described therein and have no expiration date.

F1 · derivative.expiration_date: As described in the issuer's registration statement on Form S-1 (File No. 333-234324) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustment described therein and have no expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.